Allergan’s Viberzi now available in US

DUBLIN — Allergan on Monday announced the U.S . availability of its irritable bowel syndrome with diarrhea (IBS-D), Viberzi (eluxadoline). The drug is an oral medication that is indicated to relieve the diarrhea and abdominal pain associated with IBS-D.  

 

“We are excited about the launch of Viberzi, which addresses an unmet need among IBS-D patients seeking a treatment to manage their symptoms proactively,” Allergan president and EVP branded pharma William Meury said. “This introduction reaffirms Allergan’s commitment to providing a new treatment option that serves to help gastroenterologists reach better outcomes for their patients.”